129 related articles for article (PubMed ID: 1520875)
21. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
[TBL] [Abstract][Full Text] [Related]
22. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
[TBL] [Abstract][Full Text] [Related]
23. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
Bu G; Morton PA; Schwartz AL
J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401
[TBL] [Abstract][Full Text] [Related]
24. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.
Grobmyer SR; Kuo A; Orishimo M; Okada SS; Cines DB; Barnathan ES
J Biol Chem; 1993 Jun; 268(18):13291-300. PubMed ID: 7685759
[TBL] [Abstract][Full Text] [Related]
25. Oversulfated fucoidan and heparin suppress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endothelial cells: their possible mechanism of action.
Soeda S; Fujii N; Shimeno H; Nagamatsu A
Biochim Biophys Acta; 1995 Oct; 1269(1):85-90. PubMed ID: 7578276
[TBL] [Abstract][Full Text] [Related]
26. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
27. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
28. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
[TBL] [Abstract][Full Text] [Related]
29. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
30. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator.
Lijnen HR; Van Hoef B; Collen D
J Biol Chem; 1991 Mar; 266(7):4041-4. PubMed ID: 1900284
[TBL] [Abstract][Full Text] [Related]
31. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
32. Binding of recombinant variants of human tissue-type plasminogen activator (t-PA) to human umbilical vein endothelial cells.
Stockinger H; Kubbies M; Rudolph R; Stern A; Kohnert U; Fischer S
Thromb Res; 1992 Sep; 67(5):589-99. PubMed ID: 1333104
[TBL] [Abstract][Full Text] [Related]
33. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
Gaussem P; Anglés-Cano E
Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
[TBL] [Abstract][Full Text] [Related]
34. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells.
Shi GY; Hau JS; Wang SJ; Wu IS; Chang BI; Lin MT; Chow YH; Chang WC; Wing LY; Jen CJ
J Biol Chem; 1992 Sep; 267(27):19363-8. PubMed ID: 1388168
[TBL] [Abstract][Full Text] [Related]
35. Effects of a low molecular weight heparin, bemiparin, and unfractionated heparin on hemostatic properties of endothelium.
Pérez-Ruiz A; Montes R; Carrasco P; Rocha E
Clin Appl Thromb Hemost; 2002 Jan; 8(1):65-71. PubMed ID: 11991242
[TBL] [Abstract][Full Text] [Related]
36. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
37. Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action.
Soeda S; Kozako T; Iwata K; Shimeno H
Biochim Biophys Acta; 2000 Jun; 1497(1):127-34. PubMed ID: 10838166
[TBL] [Abstract][Full Text] [Related]
38. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
Booyse FM; Lin PH; Traylor M; Bruce R
J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
[TBL] [Abstract][Full Text] [Related]
39. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells.
Thompson EA; Nelles L; Collen D
Eur J Biochem; 1991 Nov; 201(3):627-32. PubMed ID: 1935958
[TBL] [Abstract][Full Text] [Related]
40. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
